A comprehensive view of Hospital / Clinical Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.
United States Patent for Tricyclic AKR1C3 Dependent KARS Inhibitors Issued to Novartis
Published:
May 08, 2024
by Pharmaceutical Patent News
|
Patent Issued for Anti-VEGF protein compositions and methods for producing the same (USPTO 11958894)
Published:
May 07, 2024
by Angiogenesis Daily
|
Regeneron Reports First Quarter 2024 Financial and Operating Results
Published:
May 03, 2024
by GlobeNewswire
|
Baxter reports first-quarter 2024 results
Published:
May 03, 2024
by Business Wire
|
Novartis to acquire preclinical-stage biotech Mariana Oncology, strengthening its radioligand therapy pipeline and research capabilities; Novartis to make upfront payment of US$1.0B, with additional US$750.0M upon reaching milestones
Published:
May 03, 2024
by PharmaBiz (India)
|
Ask us about our Transformation & Innovation market view